Bryla CMC-Reg Consulting and the Ohio Clinical Trials Collaborative Launch Co-Marketing Arrangement

Posted by Brian Ehlert in Events & News, Press Releases | Comments Off on Bryla CMC-Reg Consulting and the Ohio Clinical Trials Collaborative Launch Co-Marketing Arrangement
Working Together to Deliver Integrative Chemistry, Manufacturing and Control Development and Operational Direction Services for the Pharmaceutical Industry CLEVELAND- May 19, 2015 - The Ohio Clinical Trials Collaborative (OCTC) and Bryla CMC-Reg Consulting, LLC, of Snohomish, Wash., have entered into a co-marketing agreement to leverage the synergies of the two organizations in delivering services to [...] read more →

PacificGMP and Ohio Clinical Trials Collaborative Launch Partnership

Posted by Brian Ehlert in Events & News, Press Releases | Comments Off on PacificGMP and Ohio Clinical Trials Collaborative Launch Partnership
Collaboration Delivers Integrative Clinical Development Services for Pharmaceutical Industry CLEVELAND-- December 2, 2014--The Ohio Clinical Trials Collaborative (OCTC) and PacificGMP have entered into a co-marketing relationship to employ PacificGMP’s contracting and biopharmaceutical development services with the OCTC’s integrated research, clinical trial and core lab services. The OCTC has partnered with an outstanding array of nationally [...] read more →

Ohio Clinical Trials Collaborative Launches in European Market

Posted by Elaina Lin in Events & News, Press Releases | Comments Off on Ohio Clinical Trials Collaborative Launches in European Market

Pharmaceutical Industry Can Advance New Treatments for Human Diseases in Ohio CLEVELAND – September 29, 2014 – The Ohio Clinical Trials Collaborative (OCTC) will join 100 companies and organizations presenting at the 14th annual Biotech in Europe Forum for Global Partnering and Investment Sept. 30-Oct. 1 in Basel, Switzerland. The Biotech in Europe Forum draws […]

read more →

Novel Human Tissue Samples Available For Research and Development

Posted by Elaina Lin in Events & News, Press Releases | Comments Off on Novel Human Tissue Samples Available For Research and Development

Tissue Access Will Advance New Treatments for Human Diseases CLEVELAND — August 19, 2014 — Human tissues are extensively employed by pharmaceutical and academic researchers to identify and validate new biomarkers and drug discovery targets. Such tissues are also widely used to study the efficacy, reproducibility, and safety of experimental drug candidates against unmet clinical […]

read more →

Brain Tumor Causes and Risk Factors Elude Scientists

Experts at the American Brain Tumor Association’s annual conference report findings and dispel myths  July 25, 2014, Chicago – Today, nearly 700,000 people in the U.S. are living with a brain tumor, and yet, when it comes to pinpointing causes or risk factors, scientists are still searching for answers. “Right now, we don’t know who, we […]

read more →

Barnholtz-Sloan to Chair Neuro-Oncology Initiative for Ohio Clinical Trials Collaborative

Posted by Admin in Events & News, Press Releases | Comments Off on Barnholtz-Sloan to Chair Neuro-Oncology Initiative for Ohio Clinical Trials Collaborative

Working Group Will Advance New Treatments for Brain Tumor Patients CLEVELAND – June 26, 2014 – The Ohio Clinical Trials Collaborative (OCTC) has appointed Jill Barnholtz-Sloan, PhD, as Chair of its Neuro-Oncology Working Group. Barnholtz-Sloan is an Associate Professor at Case Western Reserve University School of Medicine, Associate Director for Clinical Informatics, Institute for Computational […]

read more →

Salata to Chair Infectious Diseases Working Group for Ohio Clinical Trials Collaborative

Posted by Admin in Events & News, Press Releases | Comments Off on Salata to Chair Infectious Diseases Working Group for Ohio Clinical Trials Collaborative

Working Group Will Advance New Treatments for Current and Emerging Infectious Diseases CLEVELAND – June 26, 2014 –The Ohio Clinical Trials Collaborative (OCTC) announces the appointment of Robert A. Salata, MD, as Chair of its Infectious Diseases Working Group. An internationally renowned infectious disease expert, Salata is Chief of Infectious Disease and HIV Medicine Division […]

read more →

Aziz to Chair Neuroscience Initiative for Ohio Clinical Trials Collaborative

Posted by Admin in Events & News, Press Releases | Comments Off on Aziz to Chair Neuroscience Initiative for Ohio Clinical Trials Collaborative

Working Group Will Advance New Treatments for Patients Suffering From Neurological Disorders CLEVELAND – June 25, 2014 – The Ohio Clinical Trials Collaborative (OCTC) announces the appointment of Dina Aziz, MSHS, CCRP, as Chair of its Neuroscience Working Group. Aziz is the Director of Research of the Neuroscience Program at The Ohio State University (OSU) […]

read more →

ClinicalRM and Ohio Clinical Trials Collaborative Launch Partnership

Posted by Admin in Events & News, Press Releases | Comments Off on ClinicalRM and Ohio Clinical Trials Collaborative Launch Partnership

Collaboration Delivers Integrative Clinical Development Services for Pharmaceutical Industry  CLEVELAND – June 24, 2014 – ClinicalRM, Inc. and the Ohio Clinical Trials Collaborative (OCTC) announce a co-marketing partnership offering joint services for clinical trials of new biologics, drugs and medical devices. The relationship will serve the organizations’ mutual customers with a full spectrum of development […]

read more →

Ohio Clinical Trials Collaborative Launches at BIO2014, Accelerating Pharmaceutical Innovation in Ohio

Posted by Admin in Events & News, Press Releases | Comments Off on Ohio Clinical Trials Collaborative Launches at BIO2014, Accelerating Pharmaceutical Innovation in Ohio

Industry Gains Access to Ohio’s Medical Institutions through Single Point of Contact CLEVELAND – JUNE 23, 2014 – The Ohio Clinical Trials Collaborative (OCTC) holds market launch at BIO2014 in San Diego, providing pharmaceutical and medical device companies centralized access to Ohio’s premier medical schools and affiliated entities for clinical trial development. 

read more →